These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 18775442)

  • 1. A gene-wide investigation on polymorphisms in the ABCG2/BRCP transporter and susceptibility to colorectal cancer.
    Campa D; Pardini B; Naccarati A; Vodickova L; Novotny J; Försti A; Hemminki K; Barale R; Vodicka P; Canzian F
    Mutat Res; 2008 Oct; 645(1-2):56-60. PubMed ID: 18775442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms in ATP-binding cassette transporter genes and interaction with diet and life style factors in relation to colorectal cancer in a Danish prospective case-cohort study.
    Kopp TI; Andersen V; Tjonneland A; Vogel U
    Scand J Gastroenterol; 2015; 50(12):1469-81. PubMed ID: 26109419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel understanding of ABC transporters ABCB1/MDR/P-glycoprotein, ABCC2/MRP2, and ABCG2/BCRP in colorectal pathophysiology.
    Andersen V; Svenningsen K; Knudsen LA; Hansen AK; Holmskov U; Stensballe A; Vogel U
    World J Gastroenterol; 2015 Nov; 21(41):11862-76. PubMed ID: 26557010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ATP-binding cassette transporter ABCG2 (BCRP) and ABCB1 (MDR1) variants are not associated with disease susceptibility, disease phenotype response to medical therapy or need for surgeryin Hungarian patients with inflammatory bowel diseases.
    Fischer S; Lakatos PL; ; Lakatos L; Kovacs A; Molnar T; Altorjay I; Papp M; Szilvasi A; Tulassay Z; Osztovits J; Papp J; Demeter P; Schwab R; Tordai A; Andrikovics H
    Scand J Gastroenterol; 2007 Jun; 42(6):726-33. PubMed ID: 17505995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Correlation of MDR1 and ABCG2 genetic polymorphisms with the efficacy and adverse events of irinotecan chemotherapy in patients with colorectal cancer].
    Sun ZW; Wang XC; Gao J; Li J; Li YY; Dang YZ; Shen L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Jun; 16(6):524-8. PubMed ID: 23801203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single nucleotide polymorphisms result in impaired membrane localization and reduced atpase activity in multidrug transporter ABCG2.
    Mizuarai S; Aozasa N; Kotani H
    Int J Cancer; 2004 Mar; 109(2):238-46. PubMed ID: 14750175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High ABCC2 and low ABCG2 gene expression are early events in the colorectal adenoma-carcinoma sequence.
    Andersen V; Vogel LK; Kopp TI; Sæbø M; Nonboe AW; Hamfjord J; Kure EH; Vogel U
    PLoS One; 2015; 10(3):e0119255. PubMed ID: 25793771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploiting a novel miR-519c-HuR-ABCG2 regulatory pathway to overcome chemoresistance in colorectal cancer.
    To KK; Leung WW; Ng SS
    Exp Cell Res; 2015 Nov; 338(2):222-31. PubMed ID: 26386386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between the ABCG2 C421A polymorphism and Alzheimer's disease.
    Fehér Á; Juhász A; László A; Pákáski M; Kálmán J; Janka Z
    Neurosci Lett; 2013 Aug; 550():51-4. PubMed ID: 23827224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comprehensive investigation on common polymorphisms in the MDR1/ABCB1 transporter gene and susceptibility to colorectal cancer.
    Campa D; Sainz J; Pardini B; Vodickova L; Naccarati A; Rudolph A; Novotny J; Försti A; Buch S; von Schönfels W; Schafmayer C; Völzke H; Hoffmeister M; Frank B; Barale R; Hemminki K; Hampe J; Chang-Claude J; Brenner H; Vodicka P; Canzian F
    PLoS One; 2012; 7(3):e32784. PubMed ID: 22396794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between the promoter methylation status of ATP-binding cassette sub-family G member 2 and drug sensitivity in colorectal cancer cell lines.
    Moon HH; Kim SH; Ku JL
    Oncol Rep; 2016 Jan; 35(1):298-306. PubMed ID: 26497773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclooxygenase-2, multidrug resistance 1, and breast cancer resistance protein gene polymorphisms and inflammatory bowel disease in the Danish population.
    Østergaard M; Ernst A; Labouriau R; Dagiliené E; Krarup HB; Christensen M; Thorsgaard N; Jacobsen BA; Tage-Jensen U; Overvad K; Autrup H; Andersen V
    Scand J Gastroenterol; 2009; 44(1):65-73. PubMed ID: 18819034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic variation in the ABCG2 gene is associated with gout risk in the Chinese Han population.
    Jiri M; Zhang L; Lan B; He N; Feng T; Liu K; Jin T; Kang L
    Clin Rheumatol; 2016 Jan; 35(1):159-63. PubMed ID: 26506822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional validation of the genetic polymorphisms of human ATP-binding cassette (ABC) transporter ABCG2: identification of alleles that are defective in porphyrin transport.
    Tamura A; Watanabe M; Saito H; Nakagawa H; Kamachi T; Okura I; Ishikawa T
    Mol Pharmacol; 2006 Jul; 70(1):287-96. PubMed ID: 16608919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel miR-203-DNMT3b-ABCG2 regulatory pathway predisposing colorectal cancer development.
    To KK; Leung WW; Ng SS
    Mol Carcinog; 2017 Feb; 56(2):464-477. PubMed ID: 27253631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ABCG2/BCRP dysfunction as a major cause of gout.
    Matsuo H; Takada T; Ichida K; Nakamura T; Nakayama A; Suzuki H; Hosoya T; Shinomiya N
    Nucleosides Nucleotides Nucleic Acids; 2011 Dec; 30(12):1117-28. PubMed ID: 22132966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of ABCG2 associated with tumor response in metastatic colorectal cancer patients receiving first-line FOLFOX therapy--preliminary evidence.
    Lin PC; Lin HH; Lin JK; Lin CC; Yang SH; Li AF; Chen WS; Chang SC
    Int J Biol Markers; 2013 Jun; 28(2):182-6. PubMed ID: 23558935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of ABCG2 dysfunction as a major factor contributing to gout.
    Matsuo H; Takada T; Ichida K; Nakamura T; Nakayama A; Takada Y; Okada C; Sakurai Y; Hosoya T; Kanai Y; Suzuki H; Shinomiya N
    Nucleosides Nucleotides Nucleic Acids; 2011 Dec; 30(12):1098-104. PubMed ID: 22132963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic Variations in ABCG2 Gene Predict Breast Carcinoma Susceptibility and Clinical Outcomes after Treatment with Anthracycline-Based Chemotherapy.
    Wu H; Liu Y; Kang H; Xiao Q; Yao W; Zhao H; Wang E; Wei M
    Biomed Res Int; 2015; 2015():279109. PubMed ID: 26634205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ABCG2 is a high-capacity urate transporter and its genetic impairment increases serum uric acid levels in humans.
    Nakayama A; Matsuo H; Takada T; Ichida K; Nakamura T; Ikebuchi Y; Ito K; Hosoya T; Kanai Y; Suzuki H; Shinomiya N
    Nucleosides Nucleotides Nucleic Acids; 2011 Dec; 30(12):1091-7. PubMed ID: 22132962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.